Amanda J Susten, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 245 Peachtree Industrial Blvd Ste 100, Sugar Hill, GA 30518 Phone: 678-541-0777 |
Aegis Group Practice Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6009 Suwanee Dam Rd, Sugar Hill, GA 30518 Phone: 479-201-2000 Fax: 479-201-4801 |
Aegis Group Practice Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5135 W Broad Street Ne, Sugar Hill, GA 30518 Phone: 800-444-6845 Fax: 479-478-2852 |
Impulse Physical Therapy Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 598 Sweetfern Ln, Sugar Hill, GA 30518 Phone: 678-250-3597 |
Mrs. Karen Marie Burgbacher, M.S.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5510 Silk Oak Way, Sugar Hill, GA 30518 Phone: 937-673-8701 |
Mrs. Emily Davis Shannon, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6421 Pierless Ave, Sugar Hill, GA 30518 Phone: 770-403-0637 |
News Archive
Fujitsu has announced the results of a joint research project it has been conducting with the Institute of Medical Science at the University of Tokyo since April 2018.
Two Dartmouth health policy experts criticize the national breast cancer charity for using misleading statistics to promote breast cancer screening.
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of its novel antibiotic, Restanza™ that support its use in a hospital setting.
› Verified 6 days ago